全文获取类型
收费全文 | 637篇 |
免费 | 63篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 48篇 |
妇产科学 | 56篇 |
基础医学 | 67篇 |
口腔科学 | 29篇 |
临床医学 | 64篇 |
内科学 | 148篇 |
皮肤病学 | 22篇 |
神经病学 | 25篇 |
特种医学 | 80篇 |
外科学 | 44篇 |
综合类 | 18篇 |
预防医学 | 8篇 |
药学 | 40篇 |
肿瘤学 | 46篇 |
出版年
2023年 | 2篇 |
2022年 | 7篇 |
2021年 | 6篇 |
2020年 | 2篇 |
2019年 | 7篇 |
2018年 | 9篇 |
2017年 | 4篇 |
2016年 | 8篇 |
2015年 | 16篇 |
2014年 | 22篇 |
2013年 | 29篇 |
2012年 | 21篇 |
2011年 | 26篇 |
2010年 | 44篇 |
2009年 | 33篇 |
2008年 | 19篇 |
2007年 | 22篇 |
2006年 | 22篇 |
2005年 | 20篇 |
2004年 | 12篇 |
2003年 | 25篇 |
2002年 | 12篇 |
2001年 | 10篇 |
2000年 | 19篇 |
1999年 | 15篇 |
1998年 | 31篇 |
1997年 | 35篇 |
1996年 | 33篇 |
1995年 | 27篇 |
1994年 | 21篇 |
1993年 | 19篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 3篇 |
1989年 | 12篇 |
1988年 | 13篇 |
1987年 | 16篇 |
1986年 | 12篇 |
1985年 | 15篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 7篇 |
1981年 | 10篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 6篇 |
1976年 | 5篇 |
1966年 | 1篇 |
1954年 | 1篇 |
排序方式: 共有705条查询结果,搜索用时 15 毫秒
81.
Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons 下载免费PDF全文
Alessio Masi Roberto Narducci Francesco Resta Carmen Carbone Kazuto Kobayashi Guido Mannaioni 《The European journal of neuroscience》2015,42(9):2699-2706
The selective vulnerability of substantia nigra pars compacta (SNc) dopaminergic (DA) neurons is an enigmatic trait of Parkinson's disease (PD), especially if compared to the remarkable resistance of closely related DA neurons in the neighboring ventral tegmental area (VTA). Overall evidence indicates that specific electrophysiological, metabolic and molecular factors underlie SNc vulnerability, although many pieces of the puzzle are still missing. In this respect, we recently demonstrated that 1‐methyl‐4‐phenylpyridinium (MPP+), the active metabolite of the parkinsonizing toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP), alters the electrophysiological properties of SNc DA neurons in vitro by inhibiting the hyperpolarization‐activated current (Ih). Here, we present an electrophysiological investigation of the functional role of Ih in the integration of synaptic inputs in identified SNc and VTA DA neurons, comparatively, in acute midbrain slices from TH‐GFP mice. We show that pharmacological suppression of Ih increases the amplitude and decay time of excitatory postsynaptic potentials, leading to temporal summation of multiple excitatory potentials at somatic level. Importantly, these effects are quantitatively more evident in SNc DA neurons. We conclude that Ih regulates the responsiveness to excitatory synaptic transmission in SNc and VTA DA neurons differentially. Finally, we present the hypothesis that Ih loss of function may be linked to PD trigger mechanisms, such as mitochondrial failure and ATP depletion, and act in concert with SNc‐specific synaptic connectivity to promote selective vulnerability. 相似文献
82.
83.
Antonella Bresin Elisa Callegari Lucilla D'Abundo Caterina Cattani Cristian Bassi Barbara Zagatti M. Grazia Narducci Elisabetta Caprini Yuri Pekarsky Carlo M. Croce Silvia Sabbioni Giandomenico Russo Massimo Negrini 《Oncotarget》2015,6(23):19807-19818
The involvement of microRNAs (miRNAs) in chronic lymphocytic leukemia (CLL) pathogenesis suggests the possibility of anti-CLL therapeutic approaches based on miRNAs. Here, we used the Eμ-TCL1 transgenic mouse model, which reproduces leukemia with a similar course and distinct immunophenotype as human B-CLL, to test miR-181b as a therapeutic agent.In vitro enforced expression of miR-181b mimics induced significant apoptotic effects in human B-cell lines (RAJI, EHEB), as well as in mouse Eμ-TCL1 leukemic splenocytes. Molecular analyses revealed that miR-181b not only affected the expression of TCL1, Bcl2 and Mcl1 anti-apoptotic proteins, but also reduced the levels of Akt and phospho-Erk1/2. Notably, a siRNA anti-TCL1 could similarly down-modulate TCL1, but exhibited a reduced or absent activity in other relevant proteins, as well as a reduced effect on cell apoptosis and viability. In vivo studies demonstrated the capability of miR-181b to reduce leukemic cell expansion and to increase survival of treated mice.These data indicate that miR-181b exerts a broad range of actions, affecting proliferative, survival and apoptotic pathways, both in mice and human cells, and can potentially be used to reduce expansion of B-CLL leukemic cells. 相似文献
84.
85.
86.
Histopathology of the thymus of patients with acute lymphoblastic leukemia and lymphoblastic lymphoma in complete clinical remission 总被引:1,自引:0,他引:1
Rappaport H; Machover D; Bearman R; Nathwani B; Lemaigre MG; Santelli G; Verley JM; Canon C; Mathe G 《Blood》1981,58(4):852-855
The histologic features of thymuses from three patients who underwent thymectomy for acute lymphoblastic leukemia or lymphoblastic lymphoma in complete clinical remission are described. The thymuses from all three patients were fibrotic with a variability in the appearance of the lobules. Some of the lobules consisted predominantly of epithelial cells with small numbers of mature appearing lymphocytes, while other lobules were expanded and composed predominantly of cells having morphological features of immature lymphoid cells consistent with residual or recurrent disease. 相似文献
87.
Groopman JE; Hartzband PI; Shulman L; Salahuddin SZ; Sarngadharan MG; McLane MF; Essex M; Gallo R 《Blood》1985,66(3):742-744
The human T-lymphotropic virus type III (HTLV-III) is the primary cause of the acquired immunodeficiency syndrome (AIDS) and related disorders (ARC). Prior studies have reported that nearly all symptomatic patients with AIDS or ARC manifest antibody to HTLV-III. This observation has engendered efforts to screen for HTLV-III, especially prior to blood donation, with assays for antibody to HTLV-III. We report the first two cases, one with AIDS and one with ARC, that are HTLV-III virus positive but antibody negative. Accurate diagnosis of HTLV-III infection in some cases may require direct virus culture or tests for antigen. In addition, lack of HTLV-III antibody may indicate an atypical clinical course of AIDS. 相似文献
88.
Kang SM Narducci MG Lazzeri C Mongiovì AM Caprini E Bresin A Martelli F Rothstein J Croce CM Cooper MD Russo G 《Blood》2005,105(3):1288-1294
TCL1, the overexpression of which may result in T-cell leukemia, is normally expressed in early embryonic tissues, the ovary, and lymphoid lineage cells. Our analysis of mouse B-lineage cells indicates that Tcl1 expression is initiated in pro-B cells and persists in splenic marginal zone and follicular B cells. T-lineage Tcl1 expression begins in thymocyte progenitors, continues in CD4(+)CD8(+) thymocytes, and is extinguished in mature T cells. In Tcl1-deficient mice, we found B lymphopoiesis to be compromised at the pre-B cell stage and T-cell lymphopoiesis to be impaired at the CD4(+)CD8(+) thymocyte stage. A corresponding increase was observed in thymocyte susceptibility to anti-CD3epsilon-induced apoptosis. Reduced numbers of splenic follicular and germinal center B cells were accompanied by impaired production of immunoglobulin G1 (IgG1) and IgG2b antibodies in response to a T-dependent antigen. The marginal zone B cells and T-cell-independent antibody responses were also diminished in Tcl1(-/-) mice. This analysis indicates a significant role for Tcl1, a coactivator of Akt signaling, in normal T- and B-cell development and function. 相似文献
89.
Chetty R;University Health Network Princess Margaret Hospital University Avenue Fourth Floor Suite Toronto ON MG M Canada. runjan.chetty@uhn.on.ca 《Journal of clinical gastroenterology》2003,37(1):23-27
GOALS: The purpose of this review is to look at the evidence presented in the literature on the immunoexpression of p27 in cancers of the gastrointestinal tract and liver. BACKGROUND: Cell cycle proteins have been shown to play an important role in the oncogenesis of many tumors. Several of these proteins have been examined in concert and in isolation, and some have been put forward as putative tumor markers. p27, which is an important inhibitory protein in the cell cycle and belonging to a group of cyclin-dependent kinase inhibitors, has also been studied in several malignancies, most notably breast, lung, bladder, and prostate cancers. Considerable work has also been done on the expression of this protein in cancers occurring within the gastrointestinal tract. RESULTS: Cancers occurring in the major sites of the gastrointestinal tract (esophagus, stomach, and colorectum) and liver show a similar pattern with regard to p27 protein levels. p27 emerges as a statistically significant predictor of survival and tumor behavior. It has been suggested that p27 loss occurs early in the carcinogenesis process, with dysplastic epithelium having decreased expression. The more aggressive, metastasizing cancers tend to lack p27 expression as well. Some studies have also invoked the subcellular localization of p27 (cytoplasmic versus nuclear) as also being of prognostic value. CONCLUSION: Therefore, in gastrointestinal and hepatic cancers, low p27 expression is regarded as an important adverse prognostic factor. 相似文献
90.